Client News
faCellitate announces the launch of its first product BIOFLOAT™ for improved 3D cell culture
Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study
Sterna biologicals secures EUR 12.0 million in private placement
Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial
InflaRx Reports Q1 2020 Financial & Operating Results
Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio’s contribution receives funding from “la Caixa” Banking Foundation
Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins
GBA Group Pharma: LKF focuses on SARS-CoV-2 analysis: Ongoing COVID-19 testing to maintain clinical studies
APEIRON Biologics announces financing round for the further development of the COVID-19 drug APN01